NAALADL2 and pachyonychia congenita: showed the genomic location of NAALADL2 (3q26.31–32 locus) as a region with amplifications or copy number gains found to be more prevalent in aggressive PC and associated with significant reduction in disease-free survival (Simpson et al., 2020).